NASDAQ:DRIO - DarioHealth Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $26.38
  • Forecasted Upside: 70.05 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$15.51
▼ -0.28 (-1.77%)

This chart shows the closing price for DRIO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New DarioHealth Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DRIO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DRIO

Analyst Price Target is $26.38
▲ +70.05% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for DarioHealth in the last 3 months. The average price target is $26.38, with a high forecast of $35.00 and a low forecast of $15.25. The average price target represents a 70.05% upside from the last price of $15.51.

This chart shows the closing price for DRIO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 contributing investment analysts is to buy stock in DarioHealth. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2021Alliance Global PartnersLower Price TargetNeutral$18.25 ➝ $15.25Medium
5/18/2021Stifel NicolausLower Price TargetReduce ➝ Buy$30.00 ➝ $25.00High
4/22/2021CowenInitiated CoverageOutperform$31.00High
3/22/2021Stifel NicolausInitiated CoverageBuy$30.00High
2/25/2021Cantor FitzgeraldInitiated CoverageOverweight$35.00Medium
2/8/2021AegisBoost Price TargetBuy$25.00 ➝ $35.00Low
2/1/2021Alliance Global PartnersDowngradeBuy ➝ Neutral$15.60 ➝ $22.25Low
8/17/2020AegisInitiated CoverageBuy$25.00High
8/13/2020Craig HallumBoost Price TargetBuy$8.00 ➝ $17.00High
6/22/2020ThinkEquityInitiated CoverageBuy$10.00Low
5/13/2020Craig HallumBoost Price TargetBuy$7.00 ➝ $8.00Low
3/18/2020Craig HallumLower Price TargetBuy$12.00 ➝ $7.00High
12/4/2019Craig HallumLower Price TargetBuy$20.00 ➝ $12.00High
6/6/2019Craig HallumInitiated CoverageBuy$1.50High
4/9/2018Chardan CapitalInitiated CoverageBuyHigh
12/8/2017AegisReiterated RatingBuyLow
8/29/2017AegisInitiated CoverageBuy ➝ Buy$3.00 ➝ $3.50High
3/27/2017HC WainwrightSet Price TargetBuy$8.00Medium
8/22/2016Rodman & RenshawReiterated RatingBuy$12.00N/A
(Data available from 7/23/2016 forward)
DarioHealth logo
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Tools, which are devices that integrate with applications on a user's smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine. It also sells device-specific disposables test strip cartridges, lancets, and Dario Blood Glucose Monitoring System; and Dario Smart Diabetes Management Solution, which includes tools to help diabetic patients manage their disease. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York.
Read More

Today's Range

Now: $15.51
Low: $15.33
High: $15.88

50 Day Range

MA: $18.92
Low: $14.64
High: $22.58

52 Week Range

Now: $15.51
Low: $7.10
High: $31.85

Volume

93,542 shs

Average Volume

273,596 shs

Market Capitalization

$241.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Frequently Asked Questions

What sell-side analysts currently cover shares of DarioHealth?

The following Wall Street sell-side analysts have issued reports on DarioHealth in the last twelve months: Aegis, Alliance Global Partners, Cantor Fitzgerald, Cowen Inc, Craig Hallum, Stifel Nicolaus, and TheStreet.
View the latest analyst ratings for DRIO.

What is the current price target for DarioHealth?

6 Wall Street analysts have set twelve-month price targets for DarioHealth in the last year. Their average twelve-month price target is $26.38, suggesting a possible upside of 70.5%. Cantor Fitzgerald has the highest price target set, predicting DRIO will reach $35.00 in the next twelve months. Alliance Global Partners has the lowest price target set, forecasting a price of $15.25 for DarioHealth in the next year.
View the latest price targets for DRIO.

What is the current consensus analyst rating for DarioHealth?

DarioHealth currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DRIO will outperform the market and that investors should add to their positions of DarioHealth.
View the latest ratings for DRIO.

What other companies compete with DarioHealth?

How do I contact DarioHealth's investor relations team?

DarioHealth's physical mailing address is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. The company's listed phone number is 972-4770-4055 and its investor relations email address is [email protected] The official website for DarioHealth is www.mydario.com.